Past Consultations

Listed below are a number of consultations in which IPS has participated.

NICE Draft Guideline Consultation on Antimicrobial Stewardship

The closing date has now passed for IPS members to comment.  The IPS response will be posted here shortly.

HIS Consultation on The Prevention and Control of Multiresistant Gram-negative Bacteria - Recommendations of a Working Party

The closing date has now passed for IPS members to comment.  The IPS response will be posted here shortly.

Prevention and control of healthcare-associated infections: Quality improvement guide (England)

The closing date has now passed for IPS members to comment on the guide.  The IPS response will be posted here shortly.

Draft NICE (England) Infection Control Quality Standard Consultation

The closing date has now passed for IPS members to comment on the draft Infection Control quality standard.  The IPS response will be posted here shortly.

NICE Public Health Quality Standards Consultation

The closing date has now passed for IPS members to comment on the NICE public health quality standards library.

DH Health Building Note 00-01: 'General Design Principles' Consultation

The closing date has now passed for IPS members to comment on the current draft of the revised HBN.  The IPS response will be posted here shortly. 

EPIC 3 - National Guidelines for the prevention of healthcare-associated infections in NHS hospitals (England) and other acute care settings

The Department of Health has commissioned the University of West London to revise the EPIC 2 national guidelines.  EPIC 3 is scheduled for publication in November 2013.  Please on the link below to view the draft of the revised guidelines.

epic3 Consultation Response 2013 [1.6MB, PDF]

NICE IV Therapy Guideline

Please click here to view the draft intravenous fluid therapy clinical guideline.

IPS Response to IV Therapy Guideline [26KB, PDF]

Consultation on PHE led, draft scoping document for the development of guidance on the prevention and management of exotoxigenic Staphylococcus aureus

IPS response to be available shortly